Synth-Med Biotechnology is a biotechnology company that uses human blood to transport drugs directly to disease sites, such as the brain and tumors, to treat Alzheimer's disease and prostate cancer.

Synth-Med Biotechnology

Anokion is an innovative immune tolerance company focused on providing a more effective approach to treating autoimmune disease. The company develops a proprietary immune tolerance platform featuring engineered proteins that deliver targeted disease therapy without the side effects of broad immunosuppression.

Anokion

Nix Biosensors develops hydration monitoring technology that analyzes sweat to provide users with personalized hydration data in real time.

Nix Biosensors

Paragraf is the first company in the world to mass produce graphene-based electronic devices using standard semiconductor processes. They bring to market differentiated graphene-based electronics as standard products, such as magnetic sensors and biosensors. They solve important problems in various industries, including automotive, industrial automation, consumer, diagnostics, and agritech.

Metric
Company Name	Synth-Med Biotechnology	Anokion	Nix Biosensors	Paragraf
Symbol
MSH ID	COM:SYNTH-MED	COM:ANOKION	COM:NIXBIOSENSORS	COM:PARAGRAF
Market	PRIVATE	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Healthcare & Health Services	Healthcare & Health Services	Technology
Industry	Biotechnology	Biotechnology	Health Technology	Semiconductor Manufacturing
Country	CA	US	US	GB
Stage
Employee Count				144
Website	synth-med.com	anokion.com	nixbiosensors.com	paragraf.com
LinkedIn				paragrafltd
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

SYNT

COM:SYNTH-MED

Synth-Med Biotechnology

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue